XCUR · Exicure, Inc.
What's happening
- XCUR is down 1.94% today, trading at $1.01. — Live quote
- It's trading within 3% of its 52-week low ($0.94). (Finnhub fundamentals)
- Volume today (240) is well below its 3-month average of 297,380. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 15 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-8.30 actual vs. $-6.12 estimated (-35.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2023-01-01 (6 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $12.3M | $27.9M | $24.1M | $44.4M | $81.7M |
| P/E | -1.54 | -7.19 | -7.66 | -34.12 | 166.73 |
| Price/Book | 12.62 | 13.28 | 3.47 | 5.01 | 7.18 |
| EV/EBITDA | -1.68 | -8.31 | -4.53 | — | — |
| ROE | -819.55% | -184.75% | -45.32% | -14.69% | 4.31% |
| ROA | -70.26% | -30.39% | -20.56% | -6.95% | 2.37% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-09-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -165.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -78.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on XCUR
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | $0 | — | — | — |
| Operating income | -$1.1M | -$1.6M | -$2.4M | -$2.5M | $2.9M | -$2.6M | -$1.2M | -$836.0K |
| Net income | -$1.1M | -$1.8M | -$2.4M | -$2.6M | $3.0M | -$1.1M | -$600.0K | -$829.0K |
| EPS (diluted) | $-0.18 | $-0.29 | $-0.39 | $-0.41 | $0.49 | $-0.57 | $-0.35 | $-0.48 |
| EPS (basic) | $-0.18 | $-0.29 | $-0.39 | $-0.41 | $0.49 | $-0.57 | $-0.35 | $-0.48 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $11.4M | $12.8M | $14.0M | $15.3M | $18.7M | $20.7M | $15.1M | $10.6M |
| Total liabilities | $10.4M | $10.7M | $10.1M | $8.3M | $9.9M | $9.3M | $8.3M | $9.1M |
| Stockholders' equity | $977.0K | $2.1M | $3.9M | $6.9M | $8.9M | $11.4M | $6.8M | $1.5M |
| Total current assets | $2.3M | $3.5M | $4.6M | $5.4M | $8.6M | $11.3M | $13.7M | $2.6M |
| Total current liabilities | $4.2M | $4.5M | $3.9M | $2.8M | $4.6M | $3.9M | $3.1M | $3.7M |
| Cash & equivalents | — | — | — | $4.4M | $7.9M | $10.4M | $12.5M | $343.0K |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $178.0K | $219.0K | $306.0K | $527.0K | $712.0K | $565.0K | $26.0K | $33.0K |
| Goodwill | $4.4M | $4.4M | $4.4M | $3.3M | $3.3M | $3.3M | $0 | — |
| Intangible assets | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $0 | — |
| Other non-current assets | $714.0K | $821.0K | $928.0K | $1.9M | $2.0M | $1.4M | $1.4M | $2.1M |
| Accounts payable | $2.2M | $2.4M | $1.7M | $1.3M | $1.8M | $1.2M | $1.0M | $1.3M |
| Accrued liabilities | $2.0M | $2.0M | $2.2M | $1.5M | $2.7M | $2.7M | $2.0M | $2.3M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 |
| Retained earnings | -$207.2M | -$206.0M | -$204.2M | -$201.3M | -$198.9M | -$196.3M | -$199.3M | -$192.1M |
| Accumulated other comprehensive income (loss) | -$2.0K | -$2.0K | -$2.0K | $102.0K | $101.0K | — | $0 | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$887.0K | -$1.1M | -$1.1M | -$3.5M | -$2.3M | -$1.6M | -$845.0K | -$449.0K |
| Investing cash flow | $0 | $0 | $455.0K | $108.0K | -$280.0K | -$2.1M | $0 | $0 |
| Financing cash flow | $0 | $0 | $0 | $0 | $0 | $1.6M | $12.4M | $0 |
| Free cash flow | -$887.0K | — | -$934.0K | -$3.4M | -$2.6M | — | -$845.0K | -$449.0K |
| Capital expenditures | $0 | — | -$213.0K | -$106.0K | $320.0K | — | $0 | $0 |
| Depreciation & amortization | $40.0K | $49.0K | $28.0K | $82.0K | $71.0K | $61.0K | $7.0K | $7.0K |
| Share-based compensation | $0 | — | $1.0K | $0 | $1.0K | $0 | $6.0K | $5.0K |
| Deferred income taxes | — | — | -$636.0K | — | — | — | $0 | — |
| Change in accounts receivable | — | — | -$1.3M | — | — | — | $506.0K | — |
| Change in accounts payable | -$260.0K | $755.0K | $404.0K | -$530.0K | $730.0K | -$427.0K | $100.0K | -$247.0K |
| Purchases of investments | — | — | $2.1M | — | — | — | $0 | $0 |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0 | $500.0K | $0 | $28.8M | -$483.0K |
| Operating income | -$4.2M | -$12.2M | -$15.0M | -$1.8M | -$62.5M |
| Net income | -$4.9M | -$9.7M | -$16.9M | -$2.6M | -$64.1M |
| EPS (diluted) | $-0.79 | $-4.75 | $-10.55 | $-0.56 | $-21.70 |
| EPS (basic) | $-0.79 | $-4.75 | $-10.55 | $-0.56 | $-21.70 |
| Operating margin | — | -$2.4K | — | -$6 | $13.0K |
| Net margin | — | -$1.9K | — | -$9 | $13.3K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $14.0M | $15.1M | $11.6M | $23.3M | $64.9M |
| Total liabilities | $10.1M | $8.3M | $8.5M | $8.4M | $53.6M |
| Stockholders' equity | $3.9M | $6.8M | $3.0M | $14.9M | $11.2M |
| Total current assets | $4.6M | $13.7M | $2.0M | $10.1M | $43.7M |
| Total current liabilities | $3.9M | $3.1M | $2.5M | $1.6M | $34.1M |
| Cash & equivalents | — | — | $816.0K | $8.6M | $34.6M |
| Marketable securities (current) | — | — | — | $0 | $4.5M |
| Accounts receivable | — | — | — | — | $0 |
| Property, plant & equipment | $306.0K | $26.0K | $54.0K | $2.5M | $3.9M |
| Goodwill | $4.4M | $0 | — | — | — |
| Intangible assets | $3.8M | $0 | — | — | — |
| Other non-current assets | $928.0K | $1.4M | $3.0M | $3.5M | $9.3M |
| Accounts payable | $1.7M | $1.0M | $1.6M | $361.0K | $3.4M |
| Accrued liabilities | $2.2M | $2.0M | $879.0K | $1.3M | $6.5M |
| Deferred revenue (current) | — | — | — | $0 | $17.3M |
| Short-term debt | — | — | — | $0 | $6.9M |
| Long-term debt | — | — | — | — | $0 |
| Other non-current liabilities | — | — | — | $0 | $656.0K |
| Common stock & paid-in capital | $1.0K | $1.0K | $0 | $0 | $0 |
| Retained earnings | -$204.2M | -$199.3M | -$189.6M | -$172.6M | -$170.1M |
| Accumulated other comprehensive income (loss) | -$2.0K | $0 | $0 | $0 | -$2.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$8.6M | -$2.9M | -$10.4M | -$35.7M | -$34.8M |
| Investing cash flow | -$1.8M | $0 | -$1.1M | $4.7M | $43.1M |
| Financing cash flow | $1.6M | $13.4M | $3.7M | -$3.1M | $1.1M |
| Free cash flow | -$8.6M | -$2.9M | -$10.4M | -$35.7M | -$35.8M |
| Capital expenditures | $1.0K | $0 | $0 | $10.0K | $968.0K |
| Depreciation & amortization | $242.0K | $28.0K | $634.0K | $1.2M | $1.1M |
| Share-based compensation | $2.0K | $22.0K | $1.3M | $1.4M | $2.9M |
| Deferred income taxes | -$636.0K | $0 | $0 | $0 | $0 |
| Change in accounts receivable | -$1.3M | $506.0K | $0 | $0 | -$11.0K |
| Change in accounts payable | $177.0K | -$193.0K | $1.3M | -$3.1M | $1.6M |
| Purchases of investments | $2.1M | $0 | $2.0M | $1.5M | $6.5M |
| Sales/maturities of investments | — | — | — | $4.0M | $4.0M |
| Debt issued | — | — | — | — | $0 |
| Debt repaid | — | — | $0 | $7.5M | $10.0M |
| Tax withholding on stock comp | — | $0 | $123.0K | $4.0K | $14.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding XCUR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2022-12-15 to 2026-07-08
Recent transactions
- Most recent: Exicure HiTron Inc. (10% owner) — Other acquisition/disposition of 117,441 shares on 2026-07-08.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Exicure HiTron Inc. | 10% owner | Other acquisition/disposition | 2026-07-08 | 117,441 |
| Miller Josh | Chief Accounting Officer | Tax withholding | 2026-02-16 | 8 |
| SANGSANGIN INVESTMENT & SECURITIES CO., LTD. | Reporting person | Open market sale | 2025-12-08 | 433,332 |
| HiTron Systems Inc. | 10% owner | Open market purchase | 2024-12-26 | 2,900,000 |
| DGP Co., Ltd. | Reporting person | Open market purchase | 2024-09-12 | 237,223 |
| CBI USA, Inc. | Reporting person | Derivative conversion | 2023-06-23 | 3,400,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-08 | Exicure HiTron Inc. | 10% owner | Other acquisition/disposition | 117,441 | $4.50 |
| 2026-06-26 | Exicure HiTron Inc. | 10% owner | Other acquisition/disposition | 253,195 | $4.50 |
| 2026-06-24 | Exicure HiTron Inc. | 10% owner | Other acquisition/disposition | 123,456 | $4.50 |
| 2026-06-23 | Exicure HiTron Inc. | 10% owner | Other acquisition/disposition | 129,183 | $4.50 |
| 2026-02-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 8 | $4.08 |
| 2026-01-21 | Exicure HiTron Inc. | 10% owner | Open market sale | 258,367 | $4.50 |
| 2026-01-16 | Exicure HiTron Inc. | 10% owner | Open market sale | 734,747 | $4.50 |
| 2026-01-07 | Exicure HiTron Inc. | 10% owner | Open market sale | 741,272 | $4.50 |
| 2025-12-08 | SANGSANGIN INVESTMENT & SECURITIES CO., LTD. | Reporting person | Open market sale | 433,332 | $8.71 |
| 2025-11-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 7 | $3.71 |
| 2025-08-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 9 | $6.65 |
| 2025-05-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 8 | $10.06 |
| 2025-02-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 9 | $10.03 |
| 2024-12-26 | HiTron Systems Inc. | 10% owner | Open market purchase | 2,900,000 | $3.00 |
| 2024-11-16 | Miller Josh | Chief Accounting Officer | Tax withholding | 7 | $2.90 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:56 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-16 | 8-K | 2026-09-16 | View on SEC.gov → |
| 2026-08-14 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-06-23 | View on SEC.gov → |
| 2026-06-30 | 8-K | 2026-06-30 | View on SEC.gov → |
| 2026-06-01 | 8-K | 2026-06-01 | View on SEC.gov → |
| 2026-05-29 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-10 | 8-K | 2026-04-08 | View on SEC.gov → |
| 2026-04-02 | 8-K | 2026-04-02 | View on SEC.gov → |
| 2026-03-27 | 8-K | 2026-03-25 | View on SEC.gov → |
| 2026-03-25 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-25 | 8-K | 2026-03-25 | View on SEC.gov → |
| 2026-02-19 | 4 | 2026-02-16 | View on SEC.gov → |
Recent news
Headlines about XCUR (Exicure, Inc.). Links open the publisher — we don’t host full articles.
-
Exicure faces USD 2.50 million equity test: USD 6.7 million values Exicure stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
Exicure gets Nasdaq extension. Nasdaq sets a USD 2.50 million test for Exicure stock
AD HOC NEWS · 2026-10-18 -
Exicure Inc (2H0.HM) Valuation Measures & Financial Statistics
Yahoo! Finance Canada · 2026-10-16 -
Exicure (XCUR) Stock Analysis: -7.44% Loss — Key Levels 2026-10-15 - Gap Down Bounce Plays
https://www.siam.in/ · 2026-10-15 -
Exicure gets Nasdaq extension as Exicure stock faces USD 2.50 million test - ad-hoc-news.de
ad-hoc-news.de · 2026-10-15 -
Exicure gets Nasdaq compliance extension
Seeking Alpha · 2026-09-16 -
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
Yahoo Finance · 2026-09-16 -
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
Yahoo Finance · 2026-08-03
No headlines in this category right now — try “All”.